Abstract Submission

PRESENTATION THEMES:  Each half-day session includes a keynote and state of the art presenter that have already been selected.  In addition, abstracts may be selected for each themed session. Submitted abstracts must fit within one of the following topic areas and you will select this topic during the submission process:

  • Anal Sac Adenocarcinoma
  • Sentinel Lymph Nodes
  • Surgical Margins
  • Interventional Oncology
  • Mast Cell Tumors

WHO CAN SUBMIT AN ABSTRACT:  Members and non-members alike may submit an abstract for this conference.

PRESENTER REGISTRATION:  All those selected to present an abstract must be registered for the conference no later than February 1, 2023.

PRESENTATION METHOD:  We intend for all presenters to be on site in Cancun.

ABSTRACT PRESENTATION RESTRICTIONS:  Multiple abstracts may be submitted by a presenter, however, any presenter may only be allowed to present one abstract within any half-day session.  The program chair for each session will determine the placement of all abstracts.  SINGLE CASE REPORTS WILL BE AUTOMATICALLY REJECTED.

LENGTH AND FORMATTING:  The entire abstract must be no longer than 250 words among all four sections (not including the title, authors, affiliations and references. Do not include that information in the body of your abstract). The abstract should include an introduction with study objectives, a brief description of the materials and methods, results and conclusions of the study. Abstracts may not include tables or graphs. Each author is fully responsible for the content of the abstract. It is best not to copy and paste abstract content into the system as irregular symbols and characters result when merging for publication. If using Greek characters, it is best to spell out the symbol as those characters don’t often merge correctly.

SUBMISSION DEADLINE:  All abstracts must be submitted online by January 6, 2023 AT 11:59 pm PST. Follow the prompts to complete the demographic information, university affiliation, presentation type, etc. Any abstract with only “data to be presented” or some iteration of this statement will be refused. Abstracts must include results and conclusion.

EDITING YOUR ABSTRACT:  You will receive a confirmation email informing you that your abstract has been submitted properly. This email will contain a link allowing you to EDIT your abstract as often as you’d like up to the submission deadline of January 6, 2023. Please DO NOT resubmit the same abstract.

GRADING & NOTIFICATION:  Submissions are reviewed and graded in mid-January. Successful applicants will be notified via email by January 18, 2023 and are required to accept or reject their assignment by January 26.

Abstracts will be graded using the following criteria:

  • Is the study relevant to the attendee group (e.g. important to the diagnosis, treatment or prognosis of a oncologic disorder, or contributes to the understanding of tumor biology?)
  • Does the study present new information?
  • Is the study design clear and appropriate?
  • Is the objective/hypothesis of the study clearly stated?
  • Is the abstract clearly and concisely written?
  • Are the study conclusions supported by the abstract content?

PRESENTATION:  Oral presentations are scheduled for 15 minutes which includes time for Q&A.  Presenters will bring their presentation on a flash drive. If you prepare your presentation on a MAC you must bring your own MAC computer AND the adapter to connect it to the projector.  The conference will NOT have a Macintosh computer available for presentations.

ABSTRACTS PRESENTED ELSEWHERE:  Abstracts presented elsewhere may be allowed as long as cases have been added or data has matured since the last presentation.

CONTACT INFORMATION:  Please contact Sandi Strother at vetcancersociety@yahoo.com with any questions regarding your presentation. If you have technical issues, please contact Lee Fent at lee.fent@gmail.com.